loading

United Therapeutics Corp Borsa (UTHR) Ultime notizie

United Therapeutics (NASDAQ:UTHR) Upgraded at StockNews.com - Defense World

pulisher
Defense World

UTC Targets Supplier of Liquidia's Lung-Disease Drug Yutrepia - Bloomberg Law

pulisher
Bloomberg Law

United Therapeutics Co. (NASDAQ:UTHR) Director Christopher Patusky Sells 1310 Shares - Defense World

pulisher
Defense World

United Therapeutics CEO sells over $1.9m in company stock - Investing.com

pulisher
Investing.com

Insider Sale: CFO and Treasurer James Edgemond Sells 40,160 Shares of United Therapeutics Corp ... - Yahoo Finance UK

pulisher
Yahoo Finance UK

United Therapeutics director sells $545,800 in stock By Investing.com - Investing.com Australia

pulisher
Investing.com Australia

United Therapeutics director sells $545,800 in stock By Investing.com - Investing.com Canada

pulisher
Investing.com Canada

United Therapeutics CFO sells over $10 million in company stock - Investing.com

pulisher
Investing.com

United Therapeutics director sells $545,800 in stock By Investing.com - Investing.com

pulisher
Investing.com

United Therapeutics director sells $545,800 in stock By Investing.com - Investing.com UK

pulisher
Investing.com UK

Insider Selling: United Therapeutics Co. (NASDAQ:UTHR) CEO Sells 3600 Shares of Stock - Defense World

pulisher
Defense World

Teacher Retirement System of Texas Cuts Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

pulisher
Defense World

Charles Schwab Investment Management Inc. Raises Stock Position in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

pulisher
MarketBeat

MannKind Outperforms As Tyvaso DPI Captures Market Share

pulisher
Seeking Alpha

United Therapeutics CEO sells over $1.9m in company stock - Investing.com Canada

pulisher
Investing.com Canada

United Therapeutics CEO sells over $1.9m in company stock - Investing.com Australia

pulisher
Investing.com Australia

United Therapeutics CEO sells over $1.9m in company stock - Investing.com

pulisher
Investing.com

United Therapeutics CEO sells over $1.9m in company stock - Investing.com UK

pulisher
Investing.com UK

Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag

pulisher
Zacks Investment Research

International Assets Investment Management LLC Purchases 8,950 Shares of United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat

pulisher
MarketBeat

United Therapeutics Co. (NASDAQ:UTHR) Shares Purchased by International Assets Investment Management LLC - Defense World

pulisher
Defense World

Metis Global Partners LLC Decreases Position in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

pulisher
Defense World

Natixis Advisors L.P. Has $3.53 Million Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World

pulisher
Defense World

National Bank of Canada FI Sells 19637 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World

pulisher
Defense World

United Therapeutics Co. (NASDAQ:UTHR) CEO Sells $951192.00 in Stock - Defense World

pulisher
Defense World

United Therapeutics chairperson and CEO sells over $1.89 million in stock - Investing.com Australia

pulisher
Investing.com Australia

United Therapeutics chairperson and CEO sells over $1.89 million in stock - Investing.com India

pulisher
Investing.com India

United Therapeutics (NASDAQ:UTHR) Hits New 1-Year High at $268.72 - MarketBeat

pulisher
MarketBeat

United Therapeutics chairperson and CEO sells over $1.89 million in stock - Investing.com

pulisher
Investing.com

United Therapeutics chairperson and CEO sells over $1.89 million in stock - Investing.com UK

pulisher
Investing.com UK

Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates

pulisher
Zacks Investment Research

Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates

pulisher
Zacks Investment Research

United Therapeutics Co. (NASDAQ:UTHR) Position Boosted by Fisher Asset Management LLC - Defense World

pulisher
Defense World

United Therapeutics chairperson and CEO sells over $1.89 million in stock - Investing.com

pulisher
Investing.com

CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss

pulisher
Zacks Investment Research

Truist Financial Corp Sells 1505 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World

pulisher
Defense World

Victory Capital Management Inc. Buys 101419 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World

pulisher
Defense World

Esperion (ESPR) Q1 Earnings Beat, Stock Up on Strong Revenues

pulisher
Zacks Investment Research

Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term - Yahoo Canada Finance

pulisher
Yahoo Canada Finance

United Therapeutics Co. (NASDAQ:UTHR) CEO Sells $934920.00 in Stock - Defense World

pulisher
Defense World

Rocket's (RCKT) Q1 Loss Narrower Than Expected, Sales Nil

pulisher
Zacks Investment Research

Perrigo (PRGO) Q1 Earnings Surpass, Sales Miss Estimates

pulisher
Zacks Investment Research

Best Momentum Stock to Buy for May 7th

pulisher
Zacks Investment Research

Best Value Stocks to Buy for May 7th

pulisher
Zacks Investment Research

Insider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR) - Yahoo Finance

pulisher
Yahoo Finance

Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR) - Yahoo Finance

pulisher
Yahoo Finance

Insider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR) - GuruFocus.com

pulisher
GuruFocus.com

United Therapeutics (UTHR) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance

pulisher
Yahoo Finance

Here's Why United Therapeutics (UTHR) is a Strong Growth Stock - Yahoo Finance

pulisher
Yahoo Finance

United Therapeutics Corporation (UTHR) Hits Fresh High: Is There Still Room to Run?

pulisher
Zacks Investment Research
$77.56
price up icon 0.77%
$149.40
price down icon 1.20%
$29.98
price up icon 1.11%
$172.85
price up icon 1.06%
$365.81
price down icon 2.87%
$90.61
price down icon 2.55%
Capitalizzazione:     |  Volume (24 ore):